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Hypothalamic neurons expressing Agouti-related
peptide (AgRP) are critical for initiating food intake,
but druggable biochemical pathways that control
this response remain elusive. Thus, genetic ablation
of insulin or leptin signaling in AgRP neurons is
predicted to reduce satiety but fails to do so.
FoxO1 is a shared mediator of both pathways, and
its inhibition is required to induce satiety. Accord-
ingly, FoxO1 ablation in AgRP neurons of mice
results in reduced food intake, leanness, improved
glucose homeostasis, and increased sensitivity to
insulin and leptin. Expression profiling of flow-sorted
FoxO1-deficient AgRP neurons identifies G-protein-
coupled receptor Gpr17 as a FoxO1 target whose
expression is regulated by nutritional status.
Intracerebroventricular injection of Gpr17 agonists
induces food intake, whereas Gpr17 antagonist
cangrelor curtails it. These effects are absent in
Agrp-Foxo1 knockouts, suggesting that pharmaco-
logical modulation of this pathway has therapeutic
potential to treat obesity.
INTRODUCTION
The prevalence of obesity has grown at an alarming rate, reach-
ing pandemic proportions. One-third of U.S. adults are obese,
leading to increased numbers of patients affected by the com-
orbidities of obesity, such as cardiovascular disease, type 2
diabetes, respiratory disorders, and cancer (Wang et al., 2011).
Considering the staggering cost and serious challenges to public
health associated with this condition, identification of biochem-
ical pathways that can be effectively and safely targeted for
obesity therapy has acquired new urgency.
Hypothalamic neurons expressing Agouti-related peptide
(AgRP) have been directly implicated in promoting feeding.
AgRP neuron activation by either light-gated Channelrhodop-
sin-2 or ligand-activated G proteins rapidly increases food intake1314 Cell 149, 1314–1326, June 8, 2012 ª2012 Elsevier Inc.(Aponte et al., 2011; Krashes et al., 2011). Conversely, acute
ablation of AgRP neurons in adulthood causes cessation of
feeding and results in starvation (Luquet et al., 2005). Despite
the established functional importance of AgRP neurons in
feeding behavior, genetic analyses of specific hormonal path-
ways that impinge on this process have yielded limited and
occasionally conflicting results. For example, transgenic overex-
pression of Agrp results in obesity, and acute intracerebroven-
tricular (ICV) delivery of AgRP or neuropeptide Y (NPY), another
peptide produced in AgRP neurons, elicits hyperphagia (Levine
et al., 2004; Ollmann et al., 1997; Rossi et al., 1998). However,
mice with loss of Agrp, Npy, or both exhibit no feeding or body
weight phenotypes andmaintain a normal response to starvation
(Qian et al., 2002).
The key anorexigenic hormones, insulin and leptin, inhibit
AgRP neurons, raising their activation threshold (Ko¨nner et al.,
2007; Takahashi and Cone, 2005). Surprisingly, though, genetic
ablation of insulin receptor in AgRP neurons has no effect
on energy homeostasis, even as it impairs insulin-mediated
suppression of hepatic glucose production (Ko¨nner et al.,
2007). Similarly, inactivation of leptin receptors in AgRP neurons
results in a mild increase of body weight without affecting
feeding behavior and energy balance (van de Wall et al., 2008).
Thus, neither pathway appears to exert obligate control over
AgRP-neuron-dependent feeding and energy homeostasis.
The goal of this study was twofold: (1) to solve the apparent
paradox of the absence of food intake abnormalities following
ablation of leptin or insulin receptors and (2) to identify alternative
pathways that regulate AgRP-neuron-dependent food intake. To
this end, we adopted a two-pronged strategy. As transcription
factor FoxO1 integrates both leptin and insulin signaling (Kim
et al., 2006; Kitamura et al., 2006), it is plausible that greater
effects in AgRP neurons might be engendered by FoxO1
ablation. Therefore, we knocked out FoxO1 in AgRP neurons
with the intent to bring about a metabolic and energy balance
phenotype that recapitulated constitutive insulin and leptin
signaling in this cell type. We found that mice lacking FoxO1 in
AgRP neurons are lean, eat less, and show improved glucose
homeostasis as well as increased insulin/leptin sensitivity.
Having achieved this goal, we sought to identify FoxO1-depen-
dent pathways that modulate energy homeostasis and can be
enlisted to develop antiobesity medications. Using transcrip-
tional profiling of flow-sorted AgRP neurons lacking FoxO1 and
functional in vivo and ex vivo testing, we identified Gpr17, a
purinergic G-protein-coupled receptor, as a prominent FoxO1
target whose pharmacological inhibition reduces food intake
and increases brain sensitivity to hormones and nutrients.
RESULTS
Generation and Analysis of Agrp-Specific FoxO1
Knockout Mice
To ablate FoxO1 in AgRP neurons, we crossed Foxo1loxP/loxP and
Agrp-ires-Cre mice (Tong et al., 2008). Cre-mediated deletion of
the loxP-flanked Foxo1 DNA resulted in null Foxo1 alleles in
AgRP neurons (hereafter Agrp-Foxo1/). To assess the extent
of Foxo1 ablation, we introduced a reporter allele encoding red
fluorescent protein upon Cre-mediated recombination (Rosa-
Tomato) into Agrp-Foxo1/ animals. The resulting Agrp-
Foxo1/;Rosa-Tomato mice displayed a red fluorescence
pattern in the arcuate nucleus (ARH) that was consistent with
AgRP neuron localization (Figure 1A). We did not detect differ-
ences in the relative number or size of ARH AgRP neurons
between wild-type and Agrp-Foxo1/mice. Immunohistochem-
istry indicated that FoxO1 was highly expressed in ARH neurons,
including AgRP neurons, of wild-type mice but was selectively
undetectable inAgRPneuronsofAgrp-Foxo1/mice (Figure1A).
Improved Energy Homeostasis in Agrp-Foxo1/ Mice
Body weight of female and male Agrp-Foxo1/ mice was
comparable to wild-type controls or trended lower without
reaching statistical significance (Figure 1B). Both female and
male Agrp-Foxo1/ mice showed altered body composition,
with a remarkable 18%–30% decrease of fat mass and a sig-
nificant 3%–5% increase of lean mass (Figure 1C).
We selected male mice of matched body weight and com-
position for calorimetry studies. We measured respiratory
exchanges, energy expenditure, and food intake. When fed ad
libitum, Agrp-Foxo1/ mice were comparable to wild-type
controls with regard to oxygen consumption (VO2), respiratory
quotient (RQ), and energy expenditure (Figures S1A–S1C
available online), but they showed reduced locomotor activity
during light and dark phases of the light cycle (Figure 1D) as
well as reduced cumulative food intake during the 24 hr period
(Figure 1E) that was accounted for by reduced intake during
the dark phase of the light cycle (Figure 1F).
To determine whether reduced food intake was due to
increased satiety, we examined mice during fasting and refeed-
ing. Male Agrp-Foxo1/ mice showed significantly reduced
locomotor activity during an overnight fast, suggesting reduced
food foraging behavior (Figure 1G). Moreover, they showed
significantly reduced rebound food intake after an overnight
fast (Figure 1H). In light of the role of FoxO1 in orexigenic and
anorexigenic neuropeptide expression (Kitamura et al., 2006;
Plum et al., 2009), we examined AgRP and aMsh levels. After
fasting, AgRP was significantly reduced in the mediobasal
hypothalamus (MBH) of male Agrp-Foxo1/ mice, whereas
aMsh was comparable to wild-type controls (Figure 1I). Agrp is
a transcriptional target of FoxO1 (Kitamura et al., 2006). Accord-ingly, we found decreased Agrp mRNA in ARH punch biopsies
from overnight-fasted Agrp-Foxo1/ mice (Figure 1I). In
contrast, transcript levels of the aMsh precursor, Pomc, were
unaltered (Figure 1I). Moreover, Agrp-Foxo1/ mice were
largely protected from high-fat diet (HDF)-induced weight gain
(Figure 1J). These data suggest that FoxO1 in AgRP neurons is
important to regulate satiety and diet-induced obesity.
Altered Hepatic Glucose Production and Gene
Expression in Agrp-Foxo1/ Mice
Given the key role of FoxO1 in hormone-dependent hepatic
glucose production (HGP) (Matsumoto et al., 2007) and the effect
of insulin receptor signaling in AgRP neurons on this process
(Ko¨nner et al., 2007), we investigated the liver response to
FoxO1 ablation in AgRP neurons. After acclimating mice to the
calorimetry cage for >72 hr, we subjected them to an overnight
fast. Shortly upon starting the fast, Agrp-Foxo1/mice showed
a more rapid drop of RQ than controls, but they had rebound
RQ similar to controls once they were refed (Figure 2A). This
finding indicates that fasted Agrp-Foxo1/ mice adapt more
rapidly from carbohydrates to fatty acids as an energy source.
We investigated whether this adaptation to fasting was due to
an inability to mobilize hepatic glycogen. To avoid confounders
due to differences in fat content (Butler and Kozak, 2010), we
performed hyperinsulinemic euglycemic clamps in mice that
were closely matched for body weight and composition.
Agrp-Foxo1/ mice had a 50% increase in glucose infusion
rates (GIR) (Figure 2B) and a 70% reduction of HGP (Figure 2C)
but had comparable disposal rates (Rd) (Figure 2D). Further-
more, when mice were challenged with pyruvate after an over-
night fast, Agrp-Foxo1/ mice had a significantly reduced rise
in glucose levels, which is consistent with decreased hepatic
gluconeogenesis (Figures 2E and 2F). Therefore, Agrp-Foxo1/
mice show altered energy partitioning during fasting and
increased metabolic flexibility.
To examine mechanisms of decreased HGP, we studied
Agrp-Foxo1/ mice after fasting and refeeding. During fasting,
mRNA levels of the gluconeogenic gene G6pc were decreased
(Figure S2A), as were those of glucokinase (Gck) (Figure S2B).
Phosphoenolpyruvate carboxykinase-1 (Pck1) and pyruvate
dehydrogenase kinase-4 (Pdk4) remained unchanged (Fig-
ure S3). During fasting, hepatic glycogenolysis is themain source
of glucose (Lin and Accili, 2011). Consistent with decreased
HGP, Agrp-Foxo1/ mice had significantly increased hepatic
glycogen and lipids after prolonged fasting (Figures S2C and
S2D). To test whether the latter was due to increased de novo
hepatic lipogenesis, we examined the expression of genes
involved in fatty acid synthesis, oxidation, and mobilization
(Figures S2E–S2G and S3). mRNAs encoding key lipogenic
enzymes were either comparable to wild-type levels (Figures
S2E and S3) or slightly decreased in Agrp-Foxo1/ mice
(Figures S2F and S3). In contrast, hepatic Mcad was expressed
at lower levels, which is consistent with the possibility that fatty
acid oxidation is decreased (Figure S2G). Other genes involved
in liver free fatty acids (FFA) metabolism were unchanged (Fig-
ure S3). These data raised the possibility that the increased
lipid accumulation in the liver of Agrp-Foxo1/ mice was due
to increased flux of FFA from adipose tissue.Cell 149, 1314–1326, June 8, 2012 ª2012 Elsevier Inc. 1315
Figure 1. Generation and Analysis of Agrp-Foxo1/ Mice
(A) Immunohistochemistry of ARH in wild-type (WT) and Agrp-Foxo1/ (KO) mice by using Rfp as a reporter of Cre-mediated recombination (red) and FoxO1
(green) to determine colocalization and DAPI to counterstain nuclei (blue). Scale bar, 50 mm.
(B) Growth curves of female and male WT and KO on chow diet.
(C) Body fat and lean mass content in female (n = 12–13 for each genotype) and male (n = 6 for each genotype) mice analyzed by MRI.
(D) Locomotor activity in light and dark phase (n = 5–8 for each genotype).
(E and F) Cumulative 24 hr (E) and dark phase food intake (F) (g of food per mouse) (n = 5–8 for each genotype).
(G) Locomotor activity during overnight fasting (n = 5 for each genotype).
(H) Rebound food intake (g/g lean body mass) after an overnight fast (n = 9 for each genotype).
(I) Hypothalamic neuropeptide (aMSH and AGRP) levels after overnight fast (n = 5–6 for each genotype). Agrp and PomcmRNA in ARH after overnight fast (n = 6
for each genotype).
(J) Percentage of body weight gain of 10-week-old mice after switching to HFD (n = 8–9).
We present data as mean ±SEM. *p < 0.05 and **p < 0.01. See also Figure S1.Altered Adipocyte Metabolism in Agrp-Foxo1/ Mice
To test this hypothesis, we examined expression of lipolytic
genes. BothHsl and Atgl showed significantly increased expres-
sion after an overnight fast (Figures 3A and 3B), whereas Mgll1316 Cell 149, 1314–1326, June 8, 2012 ª2012 Elsevier Inc.showed a nonsignificant trend toward increase only at the 6 hr
time point (Figure 3C) in Agrp-Foxo1/ mice. Consistently,
fasting plasma FFA and glycerol were elevated (Figures 3D and
3E). Glucagon levels were unchanged between control and
Figure 2. Respiratory Quotient and Glucose
Production in Agrp-Foxo1/ Mice
(A) RQ measured during fasting and refeeding in Agrp-
Foxo1/ (KO) and wild-type (WT) mice (n = 5–7 for each
genotype).
(B–D) Hyperinsulinemic euglycemic glucose clamps
showing glucose infusion rates (GIR) (B), glucose disposal
(Rd) (C), and hepatic glucose production (HGP) (D) with
insulin (3.6 mU/ml) (n = 6 for each genotype).
(E and F) Time course (E) and area under curve (AUC) (F) of
pyruvate tolerance tests (PTT) (n = 6 for each genotype).
We present data as mean ±SEM. *p < 0.05. See also
Figure S2.Agrp-Foxo1/ mice (Figure 3F). Fat pad weight decreased
in Agrp-Foxo1/ mice (Figure 3G), which is consistent with
increased fasting-induced lipolysis. Histomorphometry of
epididymal white adipose tissue (EWAT) demonstrated sig-
nificantly smaller cells in Agrp-Foxo1/ mice (Figure 3H).
Moreover, Agrp-Foxo1/ mice showed increased uncoupling
protein 1(Ucp1) in EWAT (Figure 3I). Electron microscopy re-
vealed that EWAT from Agrp-Foxo1/ mice contained larger
mitochondria of normal morphology (Figure 3J).
Increased Nutrient Signaling in CNS
of Agrp-Foxo1/ Mice
The common thread in the subphenotypes observed in Agrp-
Foxo1/ mice is the dissociation between decreased food
intake and reduced fasting response. These two aspects could
be reconciled by increased sensitivity to hormonal and nutrient
signals conveyed through AgRP neurons. To test this possibility,
we looked at hormonal and nutritional signaling events.Cell 149, 1Insulin and leptin inhibit food intake (Halaas
et al., 1995; Woods et al., 1979). We used
immunohistochemistry with phospho (p)Akt
and pStat3, respectively, to examine these
signaling pathways. Fasted Agrp-Foxo1/
mice had increased pAkt staining in MBH that
was not limited to AgRP neurons (red cells) (Fig-
ure S4A). Western blots confirmed the increase
of pAkt in MBH (Figure 4A). After refeeding,
despite decreased serum leptin (Table S1),
Agrp-Foxo1/ mice showed increased pStat3
staining in ARH (Figures 4B and 4C) and
increased hypothalamic pAkt (Figure 4D),
especially in ARH (Figure 4E). Western blots
confirmed the increase of pAkt in ARH (Fig-
ure 4F). Therefore, knocking out Foxo1 in
AgRP neurons renders mice more sensitive to
leptin and insulin signaling in the hypothalamus.
Amino acid sensing by the mammalian target
of rapamycin (mTOR) pathway promotes satiety
(Cota et al., 2006). We monitored mTOR
activity by immunohistochemistry with anti-
bodies against its substrate ribosomal protein
S6 in refed mice. ARH AgRP neurons project
to dorso-medial hypothalamus (DMH) (Bro-berger et al., 1998). Agrp-Foxo1/ mice showed increased
pS6 staining in ARH and DMH (Figures 4G and 4H). Thus,
hormone and nutrient signaling is uniformly increased in Agrp-
Foxo1/mice.
Functional and Gene Expression Analysis
of FoxO1-Deficient AgRP Neurons
To identify AgRP and Pomc neurons, we generated Agrp-
Foxo1/ mice carrying Npy-Gfp (Agrp-Foxo1/;Rosa-
Tomato;Npy-Gfp) or Pomc-Gfp transgenes (Agrp-Foxo1/;
Rosa-Tomato;Pomc-Gfp). Foxo1-ablated AgRP neurons ex-
pressed Npy-gfp, but not Pomc-gfp (Figure 5A). We conclude
that FoxO1-deficient AgRP neurons retain their neuronal
identity, thereby excluding developmental defects due to trans-
differentiation (Padilla et al., 2010). Next, we used Agrp-
Foxo1/;Rosa-Tomato;Npy-Gfp mice to flow-sort green NPY
neurons and red AgRP neurons. Fluorescence-activated cell
sorting (FACS) analysis demonstrated that 100% of AgRP314–1326, June 8, 2012 ª2012 Elsevier Inc. 1317
Figure 3. Altered White Adipose Tissue Metabo-
lism in Agrp-Foxo1/ Mice
(A–C) Expression of lipolytic genes Hsl (A), Atgl (B), and
Mgl1 (C) under the following conditions: 6 hr fast (WT n = 7,
KO n = 10), 16 hr fast (WT n = 7, KO n = 9), and 6 hr refed
(WT n = 8, KO n = 7).
(D and E) Fasting plasma nonesterified fatty acids (NEFA)
and glycerol (n = 7–11 for each genotype). Values are
normalized by epididymal fat pad weight.
(F) Fasting plasma glucagon (n = 6–11 for each genotype).
(G) Epididymal fat pad weight after 6 or 16 hr of fasting (n =
7–11 for each genotype).
(H) Histomorphometry of epididymal adipose cells size (n =
9–11 for each genotype).
(I) Representative western blot and quantification of UCP1
expression in epididymal white adipose tissue (n = 10 for
each genotype).
(J) Representative electron microscopic image illustrating
larger mitochondria in epididymal adipocytes of Agrp-
Foxo1/ mice.
We present data as mean ±SEM. *p < 0.05 and **p < 0.01.
AU, arbitrary units. See also Figure S3.neurons (labeled by Tomato in red) (Figure 5B) are also green
fluorescent protein (Gfp) positive (i.e., they express Npy-Gfp).
Having thus validated the FACS approach, we isolated mRNA
from AgRP neurons of wild-type (Foxo1loxP/+;Agrp-ires-Cre;
Rosa-Tomato) and Agrp-Foxo1/;Rosa-Tomato mice (Fig-
ure 5C) and performed transcriptome profiling. Gene set enrich-
ment analysis of the microarray data demonstrated increased
expression of genes encoding components of the electron trans-1318 Cell 149, 1314–1326, June 8, 2012 ª2012 Elsevier Inc.port chain, translation, generation of precursor
metabolites and energy, mitochondrial genome
maintenance, and cellular component biogen-
esis in FoxO1-deficient AgRP neurons (Table
S2 and Figure S4B). This anabolic gene expres-
sion profile of the mutant neurons is consistent
with a state of increased energy availability, as
one would predict based on increased insulin,
leptin, and mTOR signaling (Figure 4). In other
words, FoxO1-deficient AgRP neurons display
gene expression patterns consistent with a state
of energy sufficiency.
To explore this possibility, we examined the
electrophysiological properties ofAgRPneurons
identified using fluorescent reporters in brain
slices from wild-type and Agrp-Foxo1/ mice
(Figures 5D–5F). Under basal conditions,
FoxO1-deficient AgRP neurons had significantly
lower membrane potential and firing frequency.
Furthermore, insulin suppressed the firing
frequency of wild-type cells to 35% of basal
level, a nearly 3-fold reduction. Despite the lower
basal firing frequency, insulin further suppressed
the firing frequency of knockout neurons, with
a 100-fold reduction. Insulin caused a similar
reduction in membrane potential in wild-type
and knockout cells (20mV). Therefore, the
electrophysiological data are consistent withthe physiologic and signaling findings in Agrp-Foxo1/ mice,
indicating that knockout neurons are more insulin sensitive.
Next, we examined expression of ion channels and neuro-
transmitter receptors (Table S3 and Figure S4C). Of note,
most GABAergic receptors showed increased expression,
suggesting that GABAergic activity is increased, whereas most
glutamatergic receptors were expressed at lower levels in
FoxO1-deficient AgRP neurons, suggesting that glutamatergic
Figure 4. Increased Hypothalamic Signaling by Hormones and Nutrients in Mutant Mice
(A and F) Representative western blotting and quantitative analysis on ARH protein extracts in 6-hr-fasted Agrp-Foxo1/ (KO) and wild-type (WT) (A) mice or
4-hr-refed Agrp-Foxo1/ (KO) and wild-type (WT) (F) mice.
(B–E and G–H) Representative immunohistochemistry with pStat3 (B and C), pAkt (D and E), and pS6 (G and H) in mice fasted overnight and refed for 3–4 hr (n = 6
for each genotype). Scale bar, 100 mm.
We present data as mean ±SEM. ***p < 0.001. See also Figure S4 and Table S1.signaling is decreased. To provide a functional validation of
the mRNA measurements, we probed electrophysiological
responses of AgRP neurons identified in brain slices from control
and Agrp-Foxo1/ mice. Miniexcitatory postsynaptic currents
(mEPSC) are typically mediated by glutamatergic neurotrans-
mitters, whereas mini-inhibitory postsynaptic currents (mIPSC)
are elicited by GABAergic neurotransmitters (Pinto et al.,
2004). FoxO1-ablated AgRP neurons showed a significant
reduction of mEPSC peak amplitude (Figure 5G) but no change
in frequency (data not shown). Conversely, they showed a sig-
nificant increase of peak amplitude and size distribution of
mIPSC (Figure 5H) without significantly altered frequency (data
not shown). Therefore, the electrophysiological findings corrob-
orate the results from gene expression profiling and indicatethat Foxo1 ablation in AgRP neurons leads to increased
GABAergic and decreased glutamatergic responses, as might
be expected from altered neurotransmitter receptor expression
at the postsynaptic level. Presynaptic plasticity of NPY neurons
in ob/ob mice is modulated by acute exposure to leptin
(Pinto et al., 2004). The changes at the postsynaptic level could
partly contribute to or reflect adaptive consequences of the
anorexigenic phenotype in Agrp-Foxo1/ mice.
G-Protein-Coupled Receptor Gpr17 Is a FoxO1 Target
in AgRP Neurons
Given the favorable metabolic profile of Agrp-Foxo1/mice, we
sought to identify FoxO1 targets that mediate its effects and are
readily targetable by chemical means. Our microarray analysisCell 149, 1314–1326, June 8, 2012 ª2012 Elsevier Inc. 1319
Figure 5. FACS, RNA Profiling, and Electrophysiology of AgRP Neurons
(A) Fluorescence microscopy of ARH from Agrp-Foxo1/; Rosa-tomatomice carrying an Npy-Gfp or Pomc-Gfp transgene. FoxO1-deficient AgRP neurons (red)
retain Npy-Gfp expression (green, top), giving rise to merged yellow color (top), whereas they fail to colocalize with Pomc-Gfp (green, bottom). Scale bar, 100 mm.
(B) FACS analysis of dissociated hypothalamic neurons of Agrp-Foxo1/ mice carrying an Npy-Gfp transgene (Agrp-Foxo1/; Rosa-tomato; Npy-Gfp). Npy
neurons were sorted by green fluorescence (fluorescein isothiocyanate [FITC], horizontal axis), and AgRP neurons were identified by red fluorescence (Tomato,
vertical axis).
(C) Representative FACS analysis of dissociated hypothalamic neurons of Agrp-Foxo1/; Rosa-tomato mice and Agrp-Foxo1/loxP; Rosa-tomato mice.
(D–F) Representative traces recorded in AgRP neurons fromWT andAgrp-Foxo1/mice (D). Quantified results: firing frequency normalized toWTwithout insulin
treatment (E) and membrane potential (F). WT: insulin n = 6, WT + insulin n = 10; KO: insulin n = 11, KO + insulin n = 4.
(G andH)mEPSC (G) andmIPSC (H) recorded in AgRP neurons fromWT andAgrp-Foxo1/mice illustrating representative traces (left), peak amplitude (middle),
and size distribution (right) (mEPSC n = 30 and mIPSC n = 27–29 for each genotype).
We present data as mean ±SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Tables S2 and S3.indicated that mRNA encoding the G-protein-coupled receptor
Gpr17 was profoundly decreased in flow-sorted FoxO1-defi-
cient AgRP neurons. Gpr17 has been deorphanized as a dual
receptor for uracil nucleotides and cysteinyl-leukotrienes (Ciana1320 Cell 149, 1314–1326, June 8, 2012 ª2012 Elsevier Inc.et al., 2006). Inhibition of Gpr17 in vivo can reduce ischemic
damage in rodents, presumably by lowering neuronal excitability
(Ciana et al., 2006). In addition, purinergic receptors, including
Gpr17, have been widely reported to modulate Ca2+ and K+
Figure 6. G-Protein-Coupled Receptor Gpr17 Is a FoxO1 Target in AgRP Neurons
(A) Gpr17 mRNA levels in flow-sorted neurons and nonneurons (identified using Synapsin-Cre; Rosa-tomato mice) (n = 2 for each genotype).
(B) Gpr17 mRNA in mediobasal hypothalamus from overnight-fasted and refed mice (n = 7 for each genotype).
(C–E) Representative traces of electrophysiological recordings from the same AgRP neurons before and after cangrelor treatment (90 nM) (C). Quantified results:
firing frequency normalized to the values before cangrelor treatment (D) and membrane potential (E) (n = 9).
(F and G) Foxo1 (F) and Gpr17 (G) expression in flow-sorted AgRP neurons from WT and KO mice (n = 3 for each genotype).
(H) ChIP assay of the Gpr17 promoter in Neuro2A cells transfected with constitutively nuclear FoxO1.
(I) Endogenous Gpr17 mRNA in Neuro2A cells transfected with GFP-tagged wild-type Foxo1 (Foxo1-gfp) or constitutively nuclear Foxo1 (ADA) (n = 3 for each
genotype).
We present data as mean ±SEM. *p < 0.05, **p < 0.01, and ***p < 0.001.channels and neurotransmitter receptors (Fischer and Kru¨gel,
2007; Pugliese et al., 2009). However, neither the role of Gpr17
in satiety and glucose homeostasis nor its CNS distribution is
known (Chen et al., 2009; Lecca et al., 2008). To examine the
latter point, we labeled neurons with Rfp by intercrossing Synap-
sin-Cre and Rosa-Tomato mice, then flow-sorted neuron and
nonneuron populations andmeasuredGpr17 levels. Quantitative
PCR (qPCR) analysis showed that Gpr17 is overwhelmingly en-
riched in neurons (Figure 6A). Next, we examined Gpr17 regula-
tion in ARH punch biopsies from fasted and refed mice. Gpr17
was expressed at significantly higher levels during fasting (Fig-
ure 6B). To investigate the function of Gpr17 in AgRP neurons,
we tested the electrophysiological properties of fluorescently
labeled AgRP neurons in response to the Gpr17 antagonist, can-
grelor. Upon treatment with cangrelor, AgRP neurons showed
significantly reduced firing frequency and lower membrane
potential (Figures 6C–6E). Therefore, inhibition of Gpr17 can
affect the electrical activity of AgRP neurons in an insulin-
mimetic fashion, supporting our hypothesis.
Consistent with the microarray data, Gpr17 expression in
FoxO1-deficient AgRP neurons (Figure 6F) was dramatically
reduced (18-fold over control) (Figure 6G). Gpr17 levels are
extremely high in AgRP neurons, being comparable to b-actin
(qPCR Ct = 18.44 ± 0.02 versus 20.61 ± 0.06 for b-actin and
Gpr17, respectively). Foxo1, in contrast, is considerably less
abundant (Ct = 23.43 ± 0.03).
We investigated the possibility that Gpr17 is a direct FoxO1
target. We found potential FoxO1-binding sites by analyzing
themouseGpr17 promoter. Accordingly, chromatin immunopre-
cipitation (ChIP) assays showed that FoxO1 binds to the Gpr17
promoter (Figure 6H). Furthermore, quantitative analysis of theChIP data indicated a 40-fold enrichment of the FoxO1 ChIP
compared with IgG controls, indicating that binding is extremely
robust.
Next, we used cultured Neuro2A cells to test the role of FoxO1
in Gpr17 regulation. Endogenous Foxo1 and Gpr17 are ex-
pressed at low levels in this cell line. Transfection of either
wild-type FoxO1-Gfp or constitutively active FoxO1 (FoxO1-
alanine-aspartic acid-alanine [ADA], in which the key phosphor-
ylation sites have been mutated in order to prevent FoxO1
inactivation) (Nakae et al., 2003) significantly increased Gpr17
levels (Figure 6I).
Opposing Actions of GPR17 Agonists and Antagonists
on AgRP Neuron Signaling and Food Intake In Vivo
To test whether Gpr17 function affects ARH hormonal signaling
in vivo, we delivered cangrelor directly into the third ventricle of
mice after an overnight fast and determined the colocalization
of pStat3, pS6, and pAkt with either POMC or AgRP neurons,
which were identified by fluorescent reporter, after refeeding.
Cangrelor treatment specifically and dramatically increased
pStat3 content in AgRP neurons, but not in POMC neurons (Fig-
ure 7A, compare yellow fluorescence in the third row and lack
thereof in the second row). Cangrelor also increased pAkt (Fig-
ure 7B, third row) and pS6 (Figure 7C, third row) in a subset of
AgRP neurons without effecting detectable changes in POMC
neurons, as indicated by the dearth of yellow merged fluores-
cence in the POMC neuron panels (Figures 7B and 7C, second
row panels). This striking result indicates that Gpr17 antagonism
can directly and specifically increase pStat3 content in AgRP
neurons in vivo, with lesser increases in pS6 and pAkt. The spec-
ificity of the effect of cangrelor in AgRP neurons may not beCell 149, 1314–1326, June 8, 2012 ª2012 Elsevier Inc. 1321
Figure 7. Gpr17 Modulation Affects pSTAT3 Content of AgRP Neurons and Food Intake
(A–C) ARH immunohistochemistry of refed AgRP or POMC reporter mice with pStat3 (A), pS6 (B), and pAkt (C) following administration of cangrelor into the third
ventricle after an overnight fast. Scale bar, 100 mm.
(D) Food intake during refeeding in overnight-fasted WT and Agrp-Foxo1/mice following ICV administration of saline or cangrelor (n = 6). We present data as
mean ± SEM. *p < 0.05.
(E) ARH immunohistochemistry of refed WT and Agrp-Foxo1/ AgRP reporter mice with pStat3 following administration of LTD4 into the third ventricle after an
overnight fast. Scale bar, 100 mm.
(F) Food intake in satiated WT and Agrp-Foxo1/ mice after ICV injection of saline or Gpr17 agonist (n = 5–9). We present data as mean ±SEM. ***p < 0.001.
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unrelated to the fact that Gpr17 mRNA is exceedingly abundant
in this cell type.
To interrogate the consequences of these biochemical
changes, we assessed the effect of delivering cangrelor into
the third ventricle of mice on food intake. In wild-type mice, we
detected a significant decrease of food intake starting 1 hr after
refeeding (Figure 7D). Consistent with our previous data (Fig-
ure 1), Agrp-Foxo1/ mice had a significantly decreased re-
feeding intake during the same period of time that was
completely unaffected by cangrelor administration.
Next, we examined the consequences of activating Gpr17
in vivo. First, we delivered LTD4 directly into the third ventricle
of mice after an overnight fast and determined the colocalization
of pStat3 with AgRP neurons after refeeding. LTD4 treatment
decreased pStat3 content in AgRP neurons (Figure 7E, compare
yellow fluorescence in the first and second rows and lack
thereof in the third row). Second, based on data indicating
a synergistic effect of the two classes of Gpr17 ligands (purines
and leukotrienes) on Gpr17 signaling (Daniele et al., 2011), we
infused uridyl-diphosphate (UDP)-Glucose and LTD4 into the
third ventricle of satiated mice and measured food intake.
Activating Gpr17 by this approach rapidly induced food intake
in wild-type mice, but not in Agrp-Foxo1/ mice (Figure 7F).
Thus, functional data support the hypothesis that Gpr17 is
a direct FoxO1 target and that its decreased expression
mediates, at least partly, the anorexigenic phenotype of Agrp-
Foxo1/ mice.
DISCUSSION
In this work, we present three important findings (Figure 7G): (1)
transcription factor FoxO1 exerts integrative control of leptin,
insulin, and amino acid signaling in AgRP neurons, effectively
coordinating food intake with peripheral metabolism; (2) the
identification of a heretofore unrecognized FoxO1 pathway that
regulates food intake through the G protein-coupled receptor,
Gpr17; and (3) the profound decrease of HGP following FoxO1
ablation in AgRP neurons, effectively unifying direct and indirect
regulation of HGP control under a FoxO1-dependent mecha-
nism. The availability of Gpr17 inhibitors in the clinic lends poten-
tial relevance to our findings, providing impetus to explore this
pathway for the pharmacological treatment of obesity.
ARH Hormone Signaling Integrates Satiety and Energy
Homeostasis
Central nervous system (CNS) resistance to the two anorexient
hormones insulin and leptin is likely to be an early contributor
to the progressive weight gain that is associated with
a ‘‘Western’’ lifestyle (Schwartz et al., 2003). In addition to
a plethora of genetic studies indicating that various subpopula-
tions of ARH neurons control body weight, decreased leptin
signaling through Jak-Stat has been demonstrated early on
during the progression of diet-induced obesity (Gautron and(G) Under fasting conditions (nuclear FoxO1, indicated by the green color), Gpr17
neuropeptide secretion as well as glutamatergic activity (+ labeled synapse) and a
the FoxO1 knockout), insulin and leptin signaling concur to inactivate Foxo1 and re
synapse), this leads to decreased food intake and HGP.Elmquist, 2011). We have been attracted to studying FoxO1
because of its brisk regulation in response to hormones and
nutrients but also because it straddles leptin and insulin CNS
signaling by virtue of its opposing actions on Agrp and Pomc
expression (Kim et al., 2006; Kitamura et al., 2006). Similar to
FoxO1 ablation, transgenic overexpression of constitutive acti-
vatedStat3 in AgRPneurons leads to leanness, but not as a result
of decreased food intake (Mesaros et al., 2008). Moreover,
constitutively active Stat3 causes feedback inhibition of leptin
and insulin signaling (Ernst et al., 2009). These findings suggest
that it is necessary to simultaneously sensitize both signaling
pathways to engender an anorexient response. This contention
is borne out from studies in POMC neurons, in which ablation
of either insulin or leptin receptor had modest consequences
on metabolism and energy balance (Balthasar et al., 2004; Shi
et al., 2008), whereas combined ablation caused systemic insulin
resistance and female infertility (Hill et al., 2010). Our studies
demonstrate phenotypes in Agrp-Foxo/ mice that are not
readily detectable by manipulating either insulin or leptin path-
ways alone.
Reconciling Direct and Indirect Mechanisms of HGP
Control
The substantial decrease of HGP in Agrp-Foxo1/ mice
provides an unexpected answer to the longstanding question
on the relative roles of direct and indirect mechanisms of insulin
control over HGP. We have shown that ablation of FoxO1 in
the liver (Matsumoto et al., 2007) reduced glucose production
to the point of causing fasting hypoglycemia (Haeusler et al.,
2010). The present data are noteworthy in a couple of respects:
they show that the indirect control of insulin on HGP through the
CNS is mediated through the same signaling module utilized in
the liver, and they also show that such control trumps the role
of FFA and glycerol (Lewis et al., 1995) because Agrp-Foxo1/
mice show decreased HGP in the face of elevated levels of these
metabolites. Our data expand the conclusions reached in mice
lacking insulin receptors in AgRP neurons, indicating that the
failure of insulin inhibition of HGP in that model likely results
from unchecked FoxO1 activity (Ko¨nner et al., 2007). We should
point out that we endeavored to select mice with closely
matched body weight and composition for the clamps. Thus,
the decrease in HGP appears to occur independently of changes
to energy balance and provides (admittedly circumstantial)
evidence that insulin control of liver metabolism through the
CNS occurs independently of its effects on energy balance.
Future studies are warranted to test how this regulation is
achieved and to identify effector pathways.
The accelerated transition from carbohydrate-based to lipid-
based metabolism in Agrp-Foxo1/ mice is consistent with
increased metabolic flexibility. It might be compensatory of their
inability to mobilize hepatic glycogen, or it might reflect
increased sympathetic tone of adipose tissue, as suggested by
increased lipase expression, Ucp1 levels, and mitochondrialis induced and modulates ion channel activity, leading to increased orexigenic
lso contributing to food intake and HGP. Under fed conditions (phenocopied by
duce Gpr17 expression. Together with increasedGABAergic activity (– labeled
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content. The latter interpretation would be consistent with the
phenotype of mice lacking Pten in leptin receptor neurons
(Plum et al., 2007), although the present phenotype is consider-
ably milder.
Anabolic Profile of FoxO1-Deficient AgRP Neurons
The combination of immunohistochemical and gene profiling
studies in Agrp-Foxo1/ mice provides unprecedented insight
into the mechanics of hypothalamic FoxO1 signaling. The data
show increased basal and hormone-dependent signaling, which
is consistent with a state of chronic inhibition of the electrical
activity of these neurons. This conclusion is supported by the
unusual and remarkable gene expression profile of FoxO1-
deficient AgRP neurons, with increased anabolic pathways
related to electron transport chain, translation, generation of
precursor metabolites and energy, mitochondrial genome
maintenance, and cellular component biogenesis. Thus, we
suggest that the decreased food intake could be secondary
to this increased anabolic activity. Consistently, mTOR path-
way signaling in neurons is linked to feeding behavior (Cota
et al., 2006). Combined expression patterns of the relevant
receptors, as well as electrophysiological properties of FoxO1-
deficient AgRP neurons, are likely to increase GABAergic
and diminish glutamatergic tone, a condition that would be
expected to decrease food intake and increase metabolic
flexibility. This is conceptually consistent with recent findings
indicating that changes in energy storage and metabolic status
in AgRP neurons are associated with altered neurotransmitter
release and feeding behavior (Kaushik et al., 2011; Liu et al.,
2012; Yang et al., 2011). We postulate that this could stem
from adaptation to increased sensitivity to hormonal and nutrient
cues.
Therapeutic Prospects
Desirable as it might be to inhibit FoxO1 to treat metabolic
diseases, this transcription factor is a poor drug target (Pajvani
et al., 2011). Hence, we sought to identify a vicarious pathway
with better therapeutic prospects. Gpr17 meets several criteria
in this respect: we show it to be abundant in AgRP neurons,
regulated by nutritional status, and a FoxO1 target. Moreover,
Gpr17 antagonists mimic the effects of FoxO1 ablation on hypo-
thalamic hormone signaling. Importantly, pharmacological
inhibition of this receptor inhibits food intake, providing a ready
alternative to FoxO1 inhibition. About one-third of all approved
drugs target G-protein-coupled receptors (Erlinge, 2011).
Gpr17 antagonists are currently in clinical use for the treatment
of asthma by inhibiting leukotriene release (e.g., montelukast
and pranlukast), and cangrelor has been used as a short-acting
antiplatelet aggregation agent (Kastrati and Ndrepepa, 2009).
Therefore, the hypothesis emerging from our studies should be
easily testable.
The broad distribution of Gpr17 in the CNS raises obvious
concerns regarding its suitability as a target for the treatment
of obesity. These concerns are partly allayed by the demonstra-
tion that direct ICV infusion of the Gpr17 antagonist cangrelor
resulted in a remarkably specific activation of Stat3 phosphory-
lation in AgRP neurons (Figure 7A), whereas the agonist LTD4
caused a decrease of phospho-Stat3 (Figure 7E). This is con-1324 Cell 149, 1314–1326, June 8, 2012 ª2012 Elsevier Inc.sistent with our observation that Gpr17 levels are extraordinarily
high in this cell type (only two cycles less abundant than actin
by qPCR), and thus AgRP neurons might be singularly sensitive
to manipulations of Gpr17 despite the latter’s broad distribution.
There are currently no reported metabolic effects of these
treatments, but this may simply reflect pharmacokinetics, CNS
bioavailability, or confounders from the multiple comorbidities
associated with each therapeutic indication. Further work is
necessary before Gpr17 can be declared a bona fide target for
intervention in obesity, but our observations provide impetus to
pursue this research.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 and Gt(Rosa)26Sortm9(CAG-tdTomato)Hze mice were from The Jackson
Laboratory. The Columbia University Animal Care and Utilization Committee
approved all procedures. Normal chow diet (NCD) had 62.1% of calories
from carbohydrates, 24.6% from protein, and 13.2% from fat (PicoLab rodent
diet 20, 5053; Purina Mills). We measured weight and length to calculate body
mass index and estimated body composition by nuclear magnetic resonance
(Bruker Optics). We generated Agrp-specific FoxO1 knockouts by mating
Agrp-ires-Cre-transgenic mice (Tong et al., 2008) with Foxo1loxP/loxP mice
(Paik et al., 2007) and genotyped them as previously described. We excluded
from analyses Agrp-Foxo1/mice that showed somatic recombination owing
to stochastic embryonic expression of Agrp-ires-Cre.
Metabolic Analyses
We measured food intake and refeeding response as described (Plum et al.,
2009) by using a TSE Labmaster Platform (TSE Systems) for indirect calorim-
etry and activity measurements (Banks et al., 2008). We performed glucose
clamps as described (Okamoto et al., 2005). We used ELISA for leptin, insulin,
and glucagon measurements (Millipore) and used colorimetric assays for
plasma FFA and glycerol (Wako).
Stereotactic Injections
We performed stereotactic manipulations in 3- to 4-month-old C57BL/6
mice. We placed cannulae and allowed 1 week for recovery (1.8 mm anterior
and 0 mm lateral to bregma and 5.3 mm below the skull surface). We verified
correct positioning of the cannulae by monitoring drinking activity after
angiotensin injection. After an overnight fast and 20 min before refeeding,
we injected cangrelor (0.455 nmol) into the third ventricle and measured
food intake at the times indicated. For immunohistochemistry studies, we
perfused mice 4–5 hr after refeeding. We infused LTD4 0.02 nmol and UDP-
glucose 0.45 nmol into the third ventricle of satiated mice and measured
food intake afterwards.
Immunostaining
We processed mouse brains and cut 10-mm-thick coronal sections for immu-
nohistochemistry as described (Plum et al., 2009) by using pAkt (Cell Signaling
4060), pStat3 (Cell Signaling 9131), and pS6 antibodies (Cell Signaling 4858)
and also Foxo1 antibody (Santa Cruz, FKHR-H128, sc11350).
RNA Procedures
We extracted RNA with Trizol (Invitrogen) and reverse transcribed with
Superscript II reverse transcriptase. We performed quantitative PCR using
primers spanning introns. Primer sequences are available upon request.
Western Blotting
We used radio immunoprecipitation assay (RIPA) buffer to extract protein and
loaded an equal amount of protein for gel electrophoresis.
Chromatin Immunoprecipitation Assays
We isolated intact chromatin from cultured N2A cells by using ChIP-IT Express
Enzymatic Kit (Active Motif). Putative Foxo1 binding site on the Gpr17
promoter was identified by genomatrix software. Multiple pairs of primers
were used for the subsequent amplification of Gpr17 promoter and yielded
the same result. The pair used for electrophoresis is (forward) 50-CCACAC
AGCTTATGTAGCATTGAGG-30 and (reverse) 50-AGCAGGAAGGTCTCAGT
AACTCCC-30.
Hypothalamic Neuropeptide Assays
We prepared acid extracts from mediobasal hypothalamus and measured
AgRP and aMsh as previously described (Plum et al., 2009). We used
high-pressure liquid chromatography (HPLC) to characterize AgRP immuno-
reactivity. The elution profile of AgRP immunoactivity in the MBH of Agrp-
Foxo1/ and wild-type mice was similar and consisted primarily of
C-terminal AgRP83–132, as reported (Breen et al., 2005).
Flow Cytometry and Gene Profiling of AgRP Neurons
We dissociated mediobasal hypothalami from Agrp-Foxo1loxP/;Rosa-Tomato
and Agrp-Foxo1/;Rosa-Tomato neonates (40–50 animals per genotype)
with Papain Dissociation Kit (Worthington Biochemical). We gated live neurons
to collect Rfp-positive Foxo1+/loxP;Agrp-ires-Cre;Rfp and Foxo1loxP/loxP;
Agrp-ires-Cre;Rfp AgRP neurons. We isolated RNA with Trizol LS reagent,
amplified it (NuGEN WT-Ovation Pico RNA Amplification System), and pro-
cessed it for hybridization with Affymetrix chips (GeneChip Mouse Exon 1.0
ST Array). We used GOrilla and R for pathway analysis and heat map
generation.
Electrophysiology and Patch Clamp
We prepared 300 mm coronal ARH slices from 6- to 8-week-old mice by using
ice-cold sucrose-based cutting solution (adjusted to pH 7.3) containing (in
mM) 10 NaCl, 25 NaHCO3, 195 sucrose, 5 glucose, 2.5 KCl, 1.25 NaH2PO4,
2 Na pyruvate, 0.5 CaCl2, and 7 MgCl2 bubbled continuously with 95% O2
and 5% CO2. We allowed slices to recover for at least 45 min at room temper-
ature in recording solution (adjusted to pH 7.3) containing (in mM) 125 NaCl,
5 glucose, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2, and 1MgCl2 bubbled
continuously with 95%O2 and 5%CO2 before transferring them to a perfusion
chamber for recording. We pulled patch pipettes to resistances of 7–9 MU
and filled them with solution (adjusted to pH 7.3) containing 128 K gluconate,
10 KCl, 10 HEPES, 0.1 EGTA, 2 MgCl2, 0.3 Na-GTP, and 3 Mg-ATP. We
selected cells by using an upright microscope fitted with fluorescence optics
(Nikon) and patched under IR-DIC optics. We assessed electrical access in
the whole-cell recording mode using a small-voltage step pulse before and
at the end of the current clamp recordings. We discarded recordings in which
the series resistance had been >15MU. We acquired current clamp recordings
with no current injection by using a MultiClamp 700B amplifier and Clampex
data acquisition software (Axon Instruments). We recorded at room tempera-
ture and analyzed action potential (AP) firing frequency, membrane potential,
and AP amplitude by using MiniAnalysis (Synaptosoft). Electrophysiological
recording to measure mEPSC and mIPSC in brain slices was performed as
previously described (Pinto et al., 2004).
Statistical Analyses
We analyzed data with Student’s t test or one-way ANOVA by using GraphPad
Prism software. We used the customary threshold of p < 0.05 to declare statis-
tical significance.
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